Date of Award
Master of Public Health (MPH)
School of Public Health
The absence of commercial diagnostics, therapeutics, and vaccines hindered control efforts during the recent Zika and Ebola epidemics. This study evaluates the connectivity and productivity of both viruses’ R&D networks before, during, and after the epidemics to ascertain the ability of current R&D practices to support the development of crucial biotechnologies. Both network maps exhibited low baseline connectivity with emergent collaborative R&D practices during the identified outbreak period that correlated with increased research productivity. It is argued that formally establishing permanent collaborative, open R&D practices prior to epidemics can enhance scientific knowledge and innovation capabilities to more effectively advance commercial availability of diagnostics, therapies, and vaccines for emerging diseases.
Byler, Rebecca, "Outbreaks Reveal Deficiencies In Biotech R&d For Emerging Diseases" (2016). Public Health Theses. 1029.